Related references
Note: Only part of the references are listed.American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
Andrew S. Artz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Bendamustine for the Treatment of Chronic Lymphocytic Leukemia and Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma
Trevor W. Dennie et al.
CLINICAL THERAPEUTICS (2009)
Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma
G. Perceau et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia
R Kath et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
Share Paper
